Guest Editors
Gangcheng Zhang, E-mail: zgc-wh@outlook.com
Center of Structural Heart Disease, Zhongnan hospital of Wuhan University, Wuhan, China.
Caojin Zhang, E-mail: gdzcjpaper@163.com
Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Academy of Medical Sciences, Guangdong Provincial People’s Hospital, Guangzhou, China.
Qiguang Wang, E-mail: wqg1993@163.com
Congenital Heart Disease center in General hospital of Northern Theater Command, Liaoning, China.
Yunshan Cao, E-mail: yunshancao@126.com
Pulmonary Vascular Disease Center (PVDC) in Gansu Provincial Hospital, Lanzhou, China.
Summary
Interventional therapy of congenital heart disease has come a long way since its inception, and made significant improvements in patient outcomes. Congenital defects receiving interventional therapy varies from simple lesions such as atrial septal defect (ASD), ventricle septal defect (VSD), and patent ductus arteriosus (PDA) to complex ones in some cases. The broaden of application field requires follow-up. At the same time, advancement of sophisticated theories, advanced techniques, and novel devices has brought “green” process, which is echocardiography guided, and degradable devices for the interventional therapy of congenital heart disease.
In this Special Issue, we invite high-quality submissions of impressive cases, clinical studies, and state-of-art reviews on, but not limited to, the highlighted objectives.
Topics of interest
• Protocols for interventional therapy of congenital heart disease
• Imaging for interventional therapy of congenital heart disease
• Outcomes for interventional therapy of congenital heart disease
• Debates of indications for interventional therapy of congenital heart disease
• Application of new techniques, novel devices for interventional therapy of congenital heart disease
Keywords
interventional therapy, congenital heart disease, novel device, imaging, outcome
Login
Register
Submit a Paper
Propose a Special lssue